• Je něco špatně v tomto záznamu ?

Synergism of BCL-2 family inhibitors facilitates selective elimination of senescent cells

D. Rysanek, P. Vasicova, JN. Kolla, D. Sedlak, L. Andera, J. Bartek, Z. Hodny

. 2022 ; 14 (16) : 6381-6414. [pub] 20220808

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc22024882

Accumulation of senescent cells in tissues with advancing age participates in the pathogenesis of several human age-associated diseases. Specific senescent secretome, the resistance of senescent cells to apoptotic stimuli, and lack of immune system response contribute to the accumulation of senescent cells and their adverse effects in tissues. Inhibition of antiapoptotic machinery, augmented in senescent cells, by BCL-2 protein family inhibitors represents a promising approach to eliminate senescent cells from tissues. This study aimed to explore synergistic and selective senolytic effects of anti-apoptotic BCL-2 family targeting compounds, particularly BH3 mimetics. Using human non-transformed cells RPE-1, BJ, and MRC-5 brought to ionizing radiation-, oncogene-, drug-induced and replicative senescence, we found synergy in combining MCL-1 selective inhibitors with other BH3 mimetics. In an attempt to uncover the mechanism of such synergy, we revealed that the surviving subpopulation of cells resistant to individually applied ABT-737/ABT-263, MIK665, ABT-199, and S63845 BCL-2 family inhibitors showed elevated MCL-1 compared to untreated control cells indicating the presence of a subset of cells expressing high MCL-1 levels and, therefore, resistant to BCL-2 inhibitors within the original population of senescent cells. Overall, we found that combining BCL-2 inhibitors can be beneficial for eliminating senescent cells, thereby enabling use of lower, potentially less toxic, doses of drugs compared to monotherapy, thereby overcoming the resistance of the subpopulation of senescent cells to monotherapy.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22024882
003      
CZ-PrNML
005      
20221031101248.0
007      
ta
008      
221017s2022 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.18632/aging.204207 $2 doi
035    __
$a (PubMed)35951353
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Rysanek, David $u Department of Genome Integrity, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic
245    10
$a Synergism of BCL-2 family inhibitors facilitates selective elimination of senescent cells / $c D. Rysanek, P. Vasicova, JN. Kolla, D. Sedlak, L. Andera, J. Bartek, Z. Hodny
520    9_
$a Accumulation of senescent cells in tissues with advancing age participates in the pathogenesis of several human age-associated diseases. Specific senescent secretome, the resistance of senescent cells to apoptotic stimuli, and lack of immune system response contribute to the accumulation of senescent cells and their adverse effects in tissues. Inhibition of antiapoptotic machinery, augmented in senescent cells, by BCL-2 protein family inhibitors represents a promising approach to eliminate senescent cells from tissues. This study aimed to explore synergistic and selective senolytic effects of anti-apoptotic BCL-2 family targeting compounds, particularly BH3 mimetics. Using human non-transformed cells RPE-1, BJ, and MRC-5 brought to ionizing radiation-, oncogene-, drug-induced and replicative senescence, we found synergy in combining MCL-1 selective inhibitors with other BH3 mimetics. In an attempt to uncover the mechanism of such synergy, we revealed that the surviving subpopulation of cells resistant to individually applied ABT-737/ABT-263, MIK665, ABT-199, and S63845 BCL-2 family inhibitors showed elevated MCL-1 compared to untreated control cells indicating the presence of a subset of cells expressing high MCL-1 levels and, therefore, resistant to BCL-2 inhibitors within the original population of senescent cells. Overall, we found that combining BCL-2 inhibitors can be beneficial for eliminating senescent cells, thereby enabling use of lower, potentially less toxic, doses of drugs compared to monotherapy, thereby overcoming the resistance of the subpopulation of senescent cells to monotherapy.
650    _2
$a apoptóza $7 D017209
650    12
$a stárnutí buněk $7 D016922
650    _2
$a lidé $7 D006801
650    _2
$a protein MCL-1 $x metabolismus $7 D064549
650    12
$a protoonkogenní proteiny c-bcl-2 $x antagonisté a inhibitory $7 D019253
655    _2
$a časopisecké články $7 D016428
700    1_
$a Vasicova, Pavla $u Department of Genome Integrity, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic
700    1_
$a Kolla, Jayaprakash Narayana $u CZ-OPENSCREEN, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic
700    1_
$a Sedlak, David $u CZ-OPENSCREEN, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic
700    1_
$a Andera, Ladislav $u Department of Genome Integrity, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic $u Biocev, Institute of Biotechnology of the Czech Academy of Sciences, Prague, Czech Republic
700    1_
$a Bartek, Jiri $u Department of Genome Integrity, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic $u Genome Integrity Unit, Danish Cancer Society Research Center, Copenhagen, Denmark
700    1_
$a Hodny, Zdenek $u Department of Genome Integrity, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic
773    0_
$w MED00172417 $t Aging $x 1945-4589 $g Roč. 14, č. 16 (2022), s. 6381-6414
856    41
$u https://pubmed.ncbi.nlm.nih.gov/35951353 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20221017 $b ABA008
991    __
$a 20221031101246 $b ABA008
999    __
$a ok $b bmc $g 1854541 $s 1176172
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 14 $c 16 $d 6381-6414 $e 20220808 $i 1945-4589 $m Aging (Albany, NY. Online) $n Aging $x MED00172417
LZP    __
$a Pubmed-20221017

Najít záznam

Citační ukazatele

    Možnosti archivace